Internet-Based Enterprise System
Qualifacts Systems, Inc.'s CareLogic application is an Internet-based enterprise management system for human services organizations, including behavioral health providers, drug and chemical dependency treatment providers, and child welfare and other human services organizations. CareLogic supports major enterprise processes, including: intake, administration, clinical, quality, financial, and basic human resources. Community Counseling Center of Mercer County, Pennsylvania, recently signed a five-year contract with Qualifacts for CareLogic.
Crisis Instruction Conference
The Crisis Prevention Institute (CPI) will host the 12th International Instructors’ Conference from July 31 to August 4 at the Adam's Mark Hotel in St. Louis. The conference's theme is “Your Gateway to Instructor Excellence: Global Standards, Strategies, and Solutions.”
The five-day event includes preconference training programs followed by two days of conference sessions that examine crisis prevention and intervention issues and trends. The conference provides Nonviolent Crisis Intervention® Certified Instructors with up-to-date information on important training topics, and Instructors can renew their certification, add Instructors to their team, obtain recertification, network with other Certified Instructors from around the world, and celebrate their commitment to Care, Welfare, Safety, and SecuritySM.
Esteam, LLC, a provider of software solutions for human services agencies, has announced that InterDyn - Artis, a provider of Microsoft e-business solutions for the mid-market, has been licensed as an Esteam Channel Development Partner.
The partnership enables InterDyn - Artis to provide human services organizations with a comprehensive solution for effectively managing their clinical, operational, and financial processes in ways that increase productivity, streamline accounting and record keeping, accelerate reimbursement, and support continuous improvement efforts. The company will market Esteam products including TOTAL: Record™, a software application that helps human services providers improve clinical and reimbursement processes, and TOTAL: Quality, a Web-based assessment management tool that simplifies data collection and analysis to help create a quality-driven organization.
InterDyn - Artis also will provide additional services to integrate Esteam software with Microsoft Dynamics™ GP back-office solutions, including general ledger, accounts payable, accounts receivable, and payroll.
Substance Abuse Treatment Protocols
Hythiam's PROMETA™ treatment protocols are designed for use by healthcare providers seeking to treat individuals diagnosed with dependencies to alcohol, cocaine, or methamphetamine, as well as combinations of these drugs. The PROMETA protocols provide for one-month of prescription medication and nutritional supplements, combined with psychosocial or other recovery-oriented therapy chosen by the patient in conjunction with the treatment provider. Hythiam recently announced that CompCare and Health Alliance Network, Inc., will market PROMETA as part of an acute medical substance abuse disease management program.
Treatment Trends Survey
The National Association of Psychiatric Health Systems (NAPHS) has released its latest Annual Survey tracking behavioral treatment trends. Trend analysis in the 2005 NAPHS Annual Survey shows a 3.5% increase in licensed beds and a 5.3% increase in set-up and staffed beds within member facilities reporting in both 2003 and 2004. Within inpatient programs, admissions and average days of care have continued to grow. In 2004, average inpatient admissions increased 4.6% and average total days of care increased 3.5%, according to trend analysis. The report contains many other findings, as well.
Alcohol Dependence Treatment
Alkermes, Inc., and Cephalon, Inc., have announced that the FDA has approved VIVITROL™ (naltrexone for extended-release injectable suspension) for the treatment of alcohol dependence. VIVITROL, the first and only once-monthly injectable medication for alcohol dependence, is indicated for alcohol-dependent patients who are able to abstain from drinking in an outpatient setting and are not actively drinking when initiating treatment. Treatment with VIVITROL should be used in combination with psychosocial support, such as counseling or group therapy. A VIVITROL injection provides medication over one month; therefore, patients do not need to make a decision to take their medication every day.
Cephalon and Alkermes expect VIVITROL to be available to physicians and patients in the United States by the end of June. VIVITROL will be available as a single dose 380 mg intramuscular injection. For full prescribing information, visit www.vivitrol.com or call (800) 896-5855.